Livagen
Also known as: Lys-Glu-Asp-Ala · KEDA
A tetrapeptide bioregulator for hepatic regeneration and epigenetic reprogramming, proven to decondense heterochromatin in elderly individuals.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~30 minutes
10 mg daily (oral, cycled)
Oral capsule
Mechanism of Action
Activates liver-specific gene expression and physically opens condensed chromatin in aging hepatocytes, restoring transcriptional activity.
Key Research Areas
Frequently Asked Questions
What is Livagen?▾
How does Livagen work?▾
What is the recommended dosage for Livagen?▾
What is the half-life of Livagen?▾
Is Livagen FDA approved?▾
Research Disclaimer
The information provided about Livagen is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.